FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Forest Pharmaceuticals Bystolic Recall

Bystolic (nebivolol) tablets, 20 mg/tablet

Forest Pharmaceuticals Inc · Earth City, MO

Risk level
Class II
Reported by FDA
Jul 9, 2014
Recall ID
D-1412-2014
Check your lot numberHow we source this data

Summary

Forest Pharmaceuticals recalled Bystolic starting Jun 19, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1412-2014 on Jul 9, 2014. Reason: Failed Dissolution Specifications: Drug failed stage III dissolution testing. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Drug failed stage III dissolution testing.

Product description

Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07.

Lot numbers, UPCs & expiration codes

Lot # A308879, Expiry: 09/2015

Where it was sold

Nationwide including Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1412-2014
Classification
Class II
Status
Terminated
Recall initiated
Jun 19, 2014
FDA report date
Jul 9, 2014
Quantity
92,544 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Forest Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-1412-2014, exactly as published.

Show all FDA fields
City
Earth City
State
MO
Status
Terminated
Country
United States
Event ID
68548
Address
13600 Shoreline Dr
Code information
Lot # A308879, Expiry: 09/2015
Postal code
63045
Report date
Jul 9, 2014
Product type
Drugs
Recall number
D-1412-2014
Classification
Class II
Recalling firm
Forest Pharmaceuticals Inc
Product quantity
92,544 Bottles
Termination date
Jan 5, 2016
Reason for recall
Failed Dissolution Specifications: Drug failed stage III dissolution testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bystolic (nebivolol) tablets, 20 mg/tablet. 7 Tablet Professional Sample Bottle, Rx Only. Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, Missouri 63045. NDC 0456-1420-07.
Distribution pattern
Nationwide including Puerto Rico.
Recall initiation date
Jun 19, 2014
Initial firm notification
Letter
Center classification date
Jun 30, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1412-2014, published Jul 9, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls